-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Insmed to Peer Perform

Benzinga·10/12/2026 12:11:27
语音播报
Wolfe Research analyst Andy Chen downgrades Insmed (NASDAQ:INSM) from Outperform to Peer Perform.